Today’s top gainers include the company Allergan plc (NYSE:AGN) which is in the industry Drugs – Generic, gaining -0.66% today. In the last week its performance is 2.67%, and 8.66% for the past quarter. Currently, Allergan plc, AGN has a target price of 293.06, so today’s gain of -0.66% is a significant step towards its target price. The GAP today is therefore 0.41%.
Allergan plc (NYSE:AGN), has a market cap of 98035.87, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 89.80%.
At the current price of 247.33, it has a dividend yield of *TBA, and its target price is 293.06. This is with a profit margin of *TBA, and total debt/equity of 0.59. Allergan plc (NYSE:AGN) has a P/E of *TBA, as well as a forward P/E of 14.38.
With a current EPS of -5.63, and a forecasted EPS growth for next year at 22.45%,Allergan plc (NYSE:AGN) has had a EPS growth for the past five years at -50.40%. For the next five years EPS growth is projected to be 9.70%.
Performance for the year is -20.95%. Since its IPO date on 2/17/1993, the total performance to date is -20.33%.
Volume today for Allergan plc (NYSE:AGN), is 885220, while its average volume is 3574.11. Whilst the total gain today was -0.66%, it did have a day high of -1.55%.
Volatility for this week has been at 1.32%, and 2.07% for the month. The 52-week low for Allergan plc, AGN has been 26.51%, while the 52-week-high has reached -27.33%.
Looking at its return of investments, which is -1.30%, and its return on assets is *TBA. Allergan plc (NYSE:AGN) has an operating margin of *TBA. With a sales growth of 48.10% quarter over quarter. Bearing in mind that Allergan plc, AGN is in the sector Healthcare, its long-term debt/equity is 0.53, and has a current ratio of 1 and 0.9 for quick ratio.
So what is the value of Allergan plc? Well its PEG is *TBA, and the P/S is 6.01, along with a P/B of 1.36. Meanwhile it has a p/cash of 43.12.